pharm res elouahabi a and ruysschaert jm formation and intracellular trafficking of lipoplexes and polyplexes mol ther rodriguez eg nonviral dna vectors for the history of ibuprofen immunization and therapy design and methods for their obtention mol med griesenbach u, geddes dm and alton ew advances in cystic fibrosis gene therapy curr opin pulm med barron lg, uyechi ls and szoka fc, jr cationic lipids are essential for the history of ibuprofen gene delivery mediated by intravenous administration of lipoplexes the history of ibuprofen gene ther li s, tan y, viroonchatapan e, pitt br and huang l targeted gene delivery the history of ibuprofen to pulmonary endothelium by antipecam antibody am j physiol the history of ibuprofen lung cell mol physiol l balyasnikova iv, yeomans dc, mcdonald �� and danilov sm antibody mediated lung endothelium targeting in vivo model on primates the history of ibuprofen gene ther balyasnikova iv, metzger r, visintine dj, dimasius v, sun zl, berestetskaya yv, mcdonald td, curiel dt, minshall rd and danilov sm selective rat the history of ibuprofen lung endothelial targeting with a new set of the history of ibuprofen monoclonal antibodies to angiotensin iconverting enzyme pulm pharmacol ther gopalan b, ito i, branch cd, stephens c, roth ja and ramesh r nanoparticle based systemic gene therapy for lung cancer molecular mechanisms the history of ibuprofen and strategies to suppress nanoparticlemediated inflammatory response technol cancer res treat li s, wu sp, whitmore m, the history of ibuprofen loeffert ej, wang l, watkins sc, pitt br and huang l effect of immune response on gene transfer to the lung via systemic administration the history of ibuprofen of cationic lipidic vectors am j physiol l the history of ibuprofen kozower bd, christofidousolomidou m, sweitzer td, muro s, buerk dg, solomides cc, albelda sm, patterson ga and muzykantov vr immunotargeting of cata lase to the the history of ibuprofen pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury nat biotechnol christofidousolomidou m, scherpereel the history of ibuprofen a, wiewrodt r, ng k, sweitzer t, arguiri e, shuvaev v, neurontin drug interactions solomides cc, albelda sm and muzykantov vr pecamdirected delivery of catalase to endothelium protects against pulmonary vascular oxidative stress am } physiol the history of ibuprofen ll dziubla td, karim a and muzykantov vr polymer nanocarriers protecting active enzyme cargo against proteolysis} control rel abraham sa, waterhouse dn, mayer ld, cullis pr, madden td and bally mb the liposomal formulation of doxorubicin meth enzymol stone wl and smith m therapeutic uses of antioxidant liposomes mol biotechnol spina d phosphodiesterase inhibitors in the treatment of inflammatory lung disease drugs peer d and margalit r tumortargeted hyaluronan nanoliposomes increase the antitumor the history of ibuprofen activity of liposomal doxorubicin in syngeneic and human xenograft the history of ibuprofen mouse tumor models neoplasia lu b, zhang jq the history of ibuprofen and yang h lungtargeting microspheres of carboplatin int } pharm mainardes rm and silva lp drug delivery systems past, present, and future cwrr drug targ panyam j and labhasetwar v biodegradable nanoparticles for drug and gene delivery to cells and tissue adv drug del rev ulrich as biophysical aspects the history of ibuprofen of using liposomes as delivery vehicles biosci rep the history of ibuprofen hans ml and lowman am biodegradable nanoparticles for drug delivery and targeting current opin solid state the history of ibuprofen mater sci discher de and eisenberg a polymer vesicles the history of ibuprofen science sakuma s, suzuki n, sudo r, hiwatari the history of ibuprofen k, kishida a and akashi m optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin int j pharm constancis a, meyrueix r, bryson n, huille s, grosselin jm, gulikkrzywicki t and soula g macromolecular colloids of diblock polyamino acids that bind insulin j coll interf sci lvov y and caruso f biocolloids with ordered urease multilayer shells as enzymatic reactors anal chem muro s, wiewrodt r, thomas a, koniaris l, albelda sm, muzykantov vr and koval m the history of ibuprofen a novel endocytic pathway induced by clustering endothelial icam or pecam j cell sci michaelis m, matousek the history of ibuprofen j, vogel ju, slavik t, langer k, cinatl j, kreuter j and schwabe d bovine seminal ribonuclease attached to nanoparticles made of polylactic acid the history of ibuprofen kills leukemia and lymphoma cell lines in vitro anticancer drugs bousquet y, swart pj, schmittcolin n, velgeroussel f, kuipers me, meijer dk, bru n, hoebeke the history of ibuprofen j and breton p molecular mechanisms of the adsorption of a model protein human serum albumin the history of ibuprofen on polymethylidene malonate nanoparticles pharm res muro s, the history of ibuprofen muzykantov vr and murciano jc characterization of endothelial internalization and targeting of antibodyenzyme conjugates in cell cultures and in laboratory animals meth mol biol ceh b, winterhalter m, frederik pm, vallner jj and lasic dd stealth liposomes from theory to product adv drug del rev discher bm, won yy, ege ds, lee ccm, bates fs, discher de and hammer da polymersomes tough vesicles made from diblock the history of ibuprofen copolymers science huang g, gao j, hu z, st john jv, ponder �� and mora d the history of ibuprofen controlled drug release from hydrogel nanoparticle networks ] control rel peppas na, wood km and blanchette jo hydrogels for oral delivery of therapeutic proteins exp opin biol ther onishi h and machida y antitumor properties of irinotecancontaining nanoparticles prepared using polydllactic acid and polyethylene glycolblock polypropylene glycolblockpolyethylene glycol biol pharm bull klibanov am improving enzymes by using them in organic solvents nature klibanov am why are enzymes less active in organic solvents than in water?